Vardenafil Hydrochloride

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

27 Suppliers, 6 USDMF, 5 CEP/COS, 2 JDMF, 8 EU WC, 2 KDMF, 11 NDC API, 19 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Forms

101 Dossiers, 32 FDA Orange Book, 35 Europe, 6 Canada, 8 South Africa, 20 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET, ORALLY DISINTEGRATING;ORAL - 10MG, TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 21 Roquette, 17 Kerry, 14 SPI Pharma, 10 Corel Pharma Chem, 10 Microlex e.U, 9 BASF, 8 Gangwal Healthcare, 8 Sigachi Industries, 6 Gangwal Chemicals, 6 Lonza Capsugel, 6 Seppic, 5 Ideal Cures Pvt Ltd, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Kima Chemical, 3 Rochem International Inc, 3 Actylis, 2 Seqens, 2 The Dow Chemical Company, 2 Prachin Chemical, 2 Vasa Pharmachem, 2 Shijiazhuang Huaxu Pharmaceutical, 2 Nomisma Healthcare, 2 DKSH, 2 DFE Pharma, 1 Zhejiang Huakang Pharmaceutical, 1 Finar, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Nanjing Well Pharmaceutical, 1 Qualicaps, 1 ACG Worldwide, 1 Ingredion Pharma Solutions, 1 Pharmatrans-Sanaq, 1 Pfanstiehl

EXCIPIENTS BY APPLICATIONS

43 Coating Systems & Additives, 43 Fillers, Diluents & Binders, 24 Controlled & Modified Release, 20 Direct Compression, 16 Taste Masking, 16 Thickeners and Stabilizers, 14 Chewable & Orodispersible Aids, 14 Film Formers & Plasticizers, 11 Granulation, 11 Lubricants & Glidants, 10 Co-Processed Excipients, 7 Topical, 7 Parenteral, 7 Disintegrants & Superdisintegrants, 5 Empty Capsules, 5 API Stability Enhancers, 5 Solubilizers, 4 Vegetarian Capsules, 3 Emulsifying Agents, 2 Coloring Agents, 2 Rheology Modifiers, 1 Soft Gelatin

GLOBAL SALES INFORMATION

16 US Medicaid Prescriptions, 22 Finished Drug Prices

MARKET PLACE

12 APIs

12 APIs

PATENTS

5 US Patents, 5 Health Canada Patents

ANALYTICAL SOLUTION(s)

2 BioAnalytical Methods, 2 USP Standards, 11 Other Ref. Standards

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 18 News

Latest U.S. Prescription Data for Drugs containing Vardenafil Hydrochloride under Medicare's Part D Prescription Drug Program. Original Data: Centers for Medicare & Medicaid Services Website

Vardenafil Hydrochloride

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

27 Suppliers

6 USDMF

5 CEP/COS

2 JDMF

8 EU WC

2 KDMF

11 NDC API

19 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

2 Suppliers

DOSSIERs // Finished Dosage Forms

101 Dossiers

32 FDA Orange Book

35 Europe

6 Canada

8 South Africa

20 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET, ORALLY DISINTEGRATING;ORAL - 10MG

TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

21 Roquette

17 Kerry

14 SPI Pharma

10 Corel Pharma Chem

10 Microlex e.U

9 BASF

8 Gangwal Healthcare

8 Sigachi Industries

6 Gangwal Chemicals

6 Lonza Capsugel

6 Seppic

5 Ideal Cures Pvt Ltd

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

3 Kima Chemical

3 Rochem International Inc

3 Actylis

2 Seqens

2 The Dow Chemical Company

2 Prachin Chemical

2 Vasa Pharmachem

2 Shijiazhuang Huaxu Pharmaceutical

2 Nomisma Healthcare

2 DKSH

2 DFE Pharma

1 Zhejiang Huakang Pharmaceutical

1 Finar

1 Qianhao Chemical (Hebei) Co., Ltd

1 Nanjing Well Pharmaceutical

1 Qualicaps

1 ACG Worldwide

1 Ingredion Pharma Solutions

1 Pharmatrans-Sanaq

1 Pfanstiehl

EXCIPIENTS BY APPLICATIONS

43 Coating Systems & Additives

43 Fillers, Diluents & Binders

24 Controlled & Modified Release

20 Direct Compression

16 Taste Masking

16 Thickeners and Stabilizers

14 Chewable & Orodispersible Aids

TABLET;ORAL - EQ 10MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 2.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 20MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons